ARS Investment Partners, LLC - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 40 filers reported holding CORREVIO PHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
ARS Investment Partners, LLC ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q4 2019$61,000
-85.8%
147,818
-31.5%
0.01%
-87.0%
Q3 2019$431,000
-52.7%
215,718
-48.9%
0.08%
-49.7%
Q2 2019$912,000
-14.6%
422,123
+24.9%
0.15%
-20.7%
Q1 2019$1,068,000
+28.5%
337,868
+1.2%
0.19%
+9.7%
Q4 2018$831,000
-25.9%
333,855
+19.7%
0.18%
+1.1%
Q3 2018$1,121,000278,9400.17%
Other shareholders
CORREVIO PHARMA CORP shareholders Q3 2019
NameSharesValueWeighting ↓
SUMMER ROAD LLC 250,000$103,0000.68%
Tamarack Advisers, LP 2,500,000$1,019,0000.23%
Virtu Financial LLC 287,972$118,0000.01%
ARS Investment Partners, LLC 147,818$61,0000.01%
Pacifica Partners Inc. 2,665$1,0000.00%
OXFORD ASSET MANAGEMENT LLP 116,653$48,0000.00%
K.J. Harrison & Partners Inc 12,860$5,0000.00%
TORONTO DOMINION BANK 153$00.00%
SCOTIA CAPITAL INC. 19,000$8,0000.00%
MORGAN STANLEY 99,852$41,0000.00%
View complete list of CORREVIO PHARMA CORP shareholders